Abstract
To determine which risk factors are relevant to the occurrence of post-herpetic neuralgia in Japanese patients with acute herpes zoster, correlations between the prolongation of pain and various disease factors were examined in 263 adult patients presenting within 10 days of the onset of rash at 17 institutions in the Hyogo region of Japan. All patients in whom pain persisted for more than 3 months were over 60 years of age. The pain also tended to be more prolonged in those with clustered vesicles, disturbed sleep and hypanaesthesia. Other factors such as underlying disease states, critically involved regions, scar tissue, generalized rash and allodynia were not relevant to the duration of pain. Although decreased pain persistence was observed in patients in whom acyclovir therapy was initiated within 72 h of the onset of symptoms in comparison with those in whom it was initiated after this time, the difference between the two groups of patients was not statistically significant. Our results suggest that advanced age, the presence of clustered vesicles, and disturbed sleep and hypanaesthesia influence the prolongation of herpes zoster pain.
References
Feb 1, 1988·Pain·K HigaB Noda
May 1, 1986·Pain·J D Loeser
Aug 1, 1986·Archives of Neurology·P N Watson, R J Evans
Jul 1, 1988·The American Journal of Medicine
May 1, 1987·The British Journal of Ophthalmology·S P HardingJ C Wells
Jul 17, 1982·Lancet·B BeanH H Balfour
Mar 1, 1983·The Journal of Infection·J McGillA Copplestone
Sep 1, 1994·Seminars in Neurology·M C Rowbotham
Mar 31, 1994·The New England Journal of Medicine·M J WoodJ Crooks
Jul 4, 1996·The New England Journal of Medicine·R G Kost, S E Straus
Feb 1, 1997·Pain·K HigaK Dan
Citations
Aug 26, 2003·Advanced Drug Delivery Reviews·David Borsook, Lino Becerra
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert H DworkinRichard J Whitley
Jan 3, 2012·The Clinical Journal of Pain·Yuko KanbayashiToyoshi Hosokawa
Mar 17, 2007·International Journal of Clinical Practice·I KurokawaK Kumano
Jun 12, 2014·BMJ Open·Kosuke KawaiCamilo J Acosta
Oct 31, 2012·International Journal of General Medicine·Monica TontodonatiGiustino Parruti
Dec 3, 2013·Expert Opinion on Pharmacotherapy·Sharon R KimStephen K Tyring
Sep 4, 2010·Current Medical Research and Opinion·Thomas RothT Kevin Murphy
Dec 18, 2013·The Journal of Pain : Official Journal of the American Pain Society·Soo Ick ChoHye One Kim
Mar 14, 2014·Practical Radiation Oncology·Meghan W MacomberStanley L Liauw
Dec 16, 2011·Médecine et maladies infectieuses·J Bruxelle, S Pinchinat
Apr 7, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Kosuke KawaiCamilo J Acosta
Jan 31, 2008·The Journal of Pain : Official Journal of the American Pain Society·Kenneth E Schmader, Robert H Dworkin
Oct 7, 2016·PloS One·Wen-Yi WangI-Jong Wang
Dec 6, 2012·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Harriet J ForbesSinéad M Langan
Apr 30, 2013·Expert Review of Neurotherapeutics·Sabine BoogaardRoberto S G M Perez
Jun 21, 2019·Pain and Therapy·Fei YangMargarita Udall
May 20, 2020·The Journal of Dermatology·Naoko ShojiUNKNOWN Amenamevir Review Team
Mar 17, 2017·BMC Infectious Diseases·Liang-Kung ChenChang Won Won